...
首页> 外文期刊>Medical oncology >Prediction of local recurrence in cervical cancer by a Cox model comprised of lymph node status, lymph-vascular space invasion, and intratumoral Th17 cell-infiltration
【24h】

Prediction of local recurrence in cervical cancer by a Cox model comprised of lymph node status, lymph-vascular space invasion, and intratumoral Th17 cell-infiltration

机译:通过Cox模型预测宫颈癌的局部复发,该模型由淋巴结状态,淋巴血管空间浸润和肿瘤内Th17细胞浸润组成

获取原文
获取原文并翻译 | 示例
           

摘要

The identification of cervical cancer patients at high risk of local recurrence is urgent to improve the selection of patients for more aggressive treatment. The immune contexture in human tumors has vital impact on clinical outcome. Our aim in the study was to establish a predictive model of local recurrence by assessing the prognostic significance of clinicopathologic features and five immune markers within the tumor microenvironment in cervical cancer. The expression of CD3, CD4, CD8, FoxP3, and IL-17 was assessed by immunohistochemistry in tumor tissue from 153 patients after radical resection for cervical cancer. Prognostic effects of these immune markers and clinicopathologic factors were evaluated by Kaplan-Meier and Cox regression analysis. Local recurrence was observed in 34 % patients (52/153). Independent predictors of tumor recurrence were lymph node status (P = 0.004), lymph-vascular space invasion (P = 0.012), and the number of intratumoral IL-17+ cells (P = 0.003). The risk of local recurrence was the highest in patients with lymph node positivity, presence of lymph-vascular space invasion, and low prevalent of intratumoral IL-17+ cells (probability, 73 %; 5-year DFS, 19 %). A Cox model composed of these three features provided a significant higher diagnostic accuracy of local recurrence than each feature alone (P 0.05). Lymph node status, lymph node space invasion, and number of intratumoral IL-17+ cells are three independent predictors for recurrence of cervical cancer. Their combination by a Cox model is highly predictive and may help to identify high-risk patients who may benefit from adjuvant chemotherapy.
机译:迫切需要确定局部复发风险高的宫颈癌患者,以改善对患者的选择,以进行更积极的治疗。人类肿瘤的免疫状况对临床结果具有至关重要的影响。我们在研究中的目的是通过评估宫颈癌的肿瘤微环境中的临床病理特征和五种免疫标记物的预后意义来建立局部复发的预测模型。通过免疫组织化学评估了153例宫颈癌根治术后患者肿瘤组织中CD3,CD4,CD8,FoxP3和IL-17的表达。通过Kaplan-Meier和Cox回归分析评估了这些免疫标志物和临床病理因素的预后。在34%的患者中观察到局部复发(52/153)。肿瘤复发的独立预测因素是淋巴结状态(P = 0.004),淋巴管空间侵犯(P = 0.012)和瘤内IL-17 +细胞数(P = 0.003)。淋巴结阳性,存在淋巴血管间隙浸润且肿瘤内IL-17 +细胞的患病率较低的患者,局部复发的风险最高(概率为73%; 5年DFS为19%)。由这三个特征组成的Cox模型比单独的每个特征提供了更高的局部复发诊断准确性(P <0.05)。淋巴结状态,淋巴结空间浸润和肿瘤内IL-17 +细胞数量是宫颈癌复发的三个独立预测因子。他们与Cox模型的组合具有高度预测性,可以帮助识别可能受益于辅助化疗的高风险患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号